LED Medical Diagnostics Announces Preliminary Q2 2016 Financial Results

Vancouver, British Columbia - July 18, 2016 - LED Medical Diagnostics Inc. ("LED Medical" or the "Company") is pleased to announce today that preliminary revenue numbers for the quarter ending June 30, 2016 are $3.7 million, as measured in US$, representing an approximate 12% increase over the prior year period of $3.3 million.  The Company's revenue for the six-month period ended June 30, 2016 was $5.8 million, representing a year-over-year increase as compared to the $5.7 million result from the first half of 2015. These revenue results are preliminary only and subject to finalization by the Company.

"Our experienced team continues to execute at a high-level, delivering solid growth in the second quarter after a softer beginning to 2016 in Q1," stated Dr. David Gane, Chief Executive Officer of LED Medical. "We continue to experience expansion of our customer base as a result of our next-generation imaging solutions combined with white-glove customer service. More than ever, LED is establishing itself as a premium provider in this space and we anticipate carrying our sales momentum into the balance of 2016."

For more information, please visit www.leddental.com.

About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc., through its wholly-owned subsidiaries LED Dental Inc. and LED Dental Ltd, provide dentists and oral health specialists with advanced diagnostic imaging products and software, in addition to the award-winning VELscope® Vx tissue fluorescence visualization technology. Backed by an experienced leadership team and dedicated to a higher level of service and support, LED Dental is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio.

The Company is currently listed on the TSX Venture Exchange (TSX-V) under the symbol "LMD", the OTCQX under the symbol "LEDIF", as well as the Frankfurt Stock Exchange under the symbol "LME". For more information, call 844.952.7327 or visit www.leddental.com/investor-relations.

LED Medical Diagnostics

Investor Relations:

Bristol Capital
Glen Akselrod
Phone: 905.326.1888, ext. 10
Email: glen@bristolir.com

Media Contact:

LED Dental
Chris Koch
Phone: 678.293.9413
Email: chris.koch@leddental.com

Corporate Contact:

LED Medical
David Gane, CEO
Phone: 604-434-4614 x227
Email: david.gane@leddental.com

Forward Looking Statement

This press release contains statements which, to the extent that they are not recitations of historical fact, may constitute forward-looking information under applicable Canadian securities legislation that involve risks and uncertainties. Such forward-looking statements or information include statements regarding, but not limited to the Company's future growth strategy, its distribution strategy and product offerings, potential expansion of the Company's technology to other medical applications or markets, or the potential introduction of new technologies by the Company. Persons reading this press release are cautioned that such statements or information are only predictions, and that the Corporation's actual future results or performance may be materially different. Factors that could cause actual events or results to differ materially from those suggested by these forward-looking statements include, but are not limited to competition risks, distributor risks, product development risks such as regulatory, design, intellectual property and other factors described in the Corporation's reports filed on SEDAR including its Annual Information Form and financial report for the year ended December 31, 2015. These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking information. All forward-looking statements made in this press release are qualified by this cautionary statement and there can be no assurance that actual results or developments anticipated by the Company will be realized. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.